XML Sitemap

This is a XML Sitemap which is supposed to be processed by search engines which follow the XML Sitemap standard like Ask.com, Bing, Google and Yahoo.
It was generated using the WordPress content management system and the Google Sitemap Generator Plugin by Arne Brachhold.
You can find more information about XML sitemaps on sitemaps.org and Google's list of sitemap programs.

URLPriorityChange frequencyLast modified (GMT)
http://www.dailyhealthindustry.it/sandoz-novartis-ema-dice-si-a-biosimilari-di-humira-abbvie-e-remicade-janssen-ID6246.html20%Monthly2017-05-31 17:14
http://www.dailyhealthindustry.it/pfizer-ce-approva-vaccino-trumemba-menb-ID6244.html20%Monthly2017-05-31 16:18
http://www.dailyhealthindustry.it/astrazeneca-in-usa-brilinta-e-bydureon-valutati-pay-for-performance-ID6242.html20%Monthly2017-05-31 14:01
http://www.dailyhealthindustry.it/jimenez-ceo-novartis-puntiamo-a-fusioni-tra-i-due-e-i-cinque-mld-di-dollari-ID6239.html20%Monthly2017-05-31 19:48
http://www.dailyhealthindustry.it/novartis-ok-da-fda-per-zykadia-come-trattamento-di-prima-linea-del-tumore-al-polmone-ID6237.html20%Monthly2017-05-31 12:50
http://www.dailyhealthindustry.it/novo-nordisk-chiede-a-fda-estensione-indicazioni-tresiba-diabete-ID6235.html20%Monthly2017-05-31 12:37
http://www.dailyhealthindustry.it/gilead-funziona-la-combo-con-bictegravir-hi-ID6231.html20%Monthly2017-05-30 17:30
http://www.dailyhealthindustry.it/msd-il-vaccino-contro-ebola-usato-in-congo-contro-epidemia-ID6229.html20%Monthly2017-05-30 17:09
http://www.dailyhealthindustry.it/roche-nuove-positive-evidenze-per-pirfenidone-fibrosi-polmonare-idiopatica-ID6226.html20%Monthly2017-05-30 17:02
http://www.dailyhealthindustry.it/nuova-vita-per-curosourf-chiesi-ID6223.html20%Monthly2017-05-30 17:03
http://www.dailyhealthindustry.it/celgene-bene-fase-iii-candidato-sclerosi-multipla-ID6221.html20%Monthly2017-05-30 16:41
http://www.dailyhealthindustry.it/dispositivi-medici-sempre-piu-a-rischio-hacker-ID6218.html20%Monthly2017-05-30 13:06
http://www.dailyhealthindustry.it/brazil-intermedica-lancia-unipo-ID6214.html20%Monthly2017-05-29 17:10
http://www.dailyhealthindustry.it/pfizer-da-panel-fda-ok-a-biosimilare-epogen-e-procrit-ID6212.html20%Monthly2017-05-29 17:15
http://www.dailyhealthindustry.it/johnson-sponsor-di-un-talent-show-su-youtube-ID6209.html20%Monthly2017-05-29 16:37
http://www.dailyhealthindustry.it/abbvie-gonzalez-ceo-grazie-ai-flussi-di-cassa-cresceremo-in-tutti-i-settori-ID6204.html20%Monthly2017-05-29 16:15
http://www.dailyhealthindustry.it/roche-e-boeringher-ingelheim-testa-a-testa-nella-fibrosi-polmonare-ID6201.html20%Monthly2017-05-29 15:47
http://www.dailyhealthindustry.it/kite-pharma-priority-review-fda-per-la-sua-terapia-car-t-ID6195.html20%Monthly2017-05-29 10:25
http://www.dailyhealthindustry.it/approvazioni-fast-track-cosa-accade-dopo-la-messa-in-commercio-dei-farmaci-ID6192.html20%Monthly2017-05-26 15:58
http://www.dailyhealthindustry.it/21st-century-oncology-per-evitare-il-fallimento-si-spera-nei-fondi-dinvestimento-ID6190.html20%Monthly2017-05-26 15:07
http://www.dailyhealthindustry.it/antitrust-uk-accusa-merck-di-concorrenza-sleale-lazienda-abbiamo-rispettato-le-regole-ID6188.html20%Monthly2017-05-30 14:40
http://www.dailyhealthindustry.it/nuovi-farmaci-gia-63-approvazioni-nel-2017-fra-fda-ed-ema-ID6186.html20%Monthly2017-05-29 11:20
http://www.dailyhealthindustry.it/transmedics-ok-fda-a-primo-device-per-trasporto-organi-ID6183.html20%Monthly2017-05-26 11:08
http://www.dailyhealthindustry.it/fondazione-msd-associazioni-pazienti-a-scuola-di-fundraising-ID6180.html20%Monthly2017-05-26 09:44
http://www.dailyhealthindustry.it/amgen-ucb-dubbi-su-sicurezza-cardiovascolare-di-romosuzumab-osteoporosi-ID6177.html20%Monthly2017-05-25 16:57
http://www.dailyhealthindustry.it/sanofi-ok-da-chmp-per-biosimilare-insulina-lispro-ID6174.html20%Monthly2017-05-25 16:31
http://www.dailyhealthindustry.it/gw-pharmaceuticals-presto-richiesta-alla-fda-per-epidiolex-epilessia-ID6170.html20%Monthly2017-05-25 15:23
http://www.dailyhealthindustry.it/digital-health-engagement-linea-comune-per-pazienti-e-medici-ID6160.html20%Monthly2017-05-24 16:20
http://www.dailyhealthindustry.it/digital-significa-cambiamento-culturale-e-investimento-a-tutti-i-livelli-ID6126.html20%Monthly2017-05-24 17:09
http://www.dailyhealthindustry.it/essere-omnichannel-per-comunicare-in-modo-giusto-ID6157.html20%Monthly2017-05-25 16:41
http://www.dailyhealthindustry.it/digital-significa-innovazione-e-sostenibilita-del-modello-di-business-ID6121.html20%Monthly2017-05-24 17:08
http://www.dailyhealthindustry.it/la-sfida-ingaggiare-i-nostri-interlocutori-anche-online-ID6116.html20%Monthly2017-05-24 17:10
http://www.dailyhealthindustry.it/il-digitale-puo-rivoluzionare-il-modo-in-cui-le-cure-arrivano-alle-persone-ID6123.html20%Monthly2017-05-24 17:10
http://www.dailyhealthindustry.it/lapproccio-multicanale-abbraccia-sia-linnovazione-che-il-tradizionale-ID6102.html20%Monthly2017-05-24 17:07
http://www.dailyhealthindustry.it/offrire-servizi-tramite-canali-digitali-ID6092.html20%Monthly2017-05-24 17:07
http://www.dailyhealthindustry.it/fda-approvazione-keytruda-msd-caso-scuola-ID6151.html20%Monthly2017-05-24 15:51
http://www.dailyhealthindustry.it/biotech-uk-un-settore-leader-che-la-brexit-potrebbe-spazzare-via-ID6149.html20%Monthly2017-05-24 14:22
http://www.dailyhealthindustry.it/dompe-ok-da-chmp-a-oxervate-cheratite-neurotrofica-ID6147.html20%Monthly2017-05-24 12:39
http://www.dailyhealthindustry.it/puma-biotechnology-da-fda-si-con-riserva-per-neratinib-cancro-al-seno-ID6142.html20%Monthly2017-05-23 17:25
http://www.dailyhealthindustry.it/recordati-accordo-con-astrazeneca-per-i-diritti-europei-di-due-farmaci-ID6131.html20%Monthly2017-05-23 17:15
http://www.dailyhealthindustry.it/novo-nordisk-si-espande-in-america-latina-continente-dellobesita-ID6128.html20%Monthly2017-05-23 17:05
http://www.dailyhealthindustry.it/g20-della-salute-i-ministri-verso-obbligatorieta-prescrizione-antibiotici-ID6111.html20%Monthly2017-05-23 13:14
http://www.dailyhealthindustry.it/sanofi-regeneron-fda-approva-sarilumab-artrite-reumatoide-ID6108.html20%Monthly2017-05-23 18:06
http://www.dailyhealthindustry.it/astrazeneca-tante-speranze-per-benralizumab-asma-ID6104.html20%Monthly2017-05-23 12:42
http://www.dailyhealthindustry.it/menarini-dallasia-un-mld-di-fatturato-entro-il-2021-ID6089.html20%Monthly2017-05-22 16:26
http://www.dailyhealthindustry.it/msd-incyte-funziona-la-combo-keytruda-epacadostat-ID6087.html20%Monthly2017-05-22 15:28
http://www.dailyhealthindustry.it/cina-il-grande-mercato-delle-malattie-rare-ID6085.html20%Monthly2017-05-22 15:01
http://www.dailyhealthindustry.it/pfizer-iterum-sperimentera-il-suo-antibiotico-sulopenem-infezioni-urinarie-ID6080.html20%Monthly2017-05-22 14:34
http://www.dailyhealthindustry.it/novartis-ok-da-chpm-per-zydakia-tumore-al-polmone-ID6075.html20%Monthly2017-05-22 17:26
http://www.dailyhealthindustry.it/msd-gardasil-utile-anche-contro-tumori-testa-e-collo-ID6070.html20%Monthly2017-05-22 12:44
http://www.dailyhealthindustry.it/aifa-pembrolizumab-keytruda-rimborsabile-per-carcinoma-polmonare-in-prima-e-seconda-linea-ID6063.html20%Monthly2017-05-19 15:38
http://www.dailyhealthindustry.it/6058-ID6058.html20%Monthly2017-05-19 14:42
http://www.dailyhealthindustry.it/shire-pronta-a-chiedere-lok-a-fda-per-lanadelumab-angoioedema-ereditario-ID6056.html20%Monthly2017-05-19 14:48
http://www.dailyhealthindustry.it/immunogen-candidato-tumore-ovaio-anche-in-combo-con-keytruda-msd-e-avastin-roche-ID6054.html20%Monthly2017-05-19 13:52
http://www.dailyhealthindustry.it/celgene-enasidenib-migliora-la-sopravvivenza-nella-leucemia-mieloide-acuta-ID6051.html20%Monthly2017-05-19 15:49
http://www.dailyhealthindustry.it/msd-keytruda-allunga-la-sopravvivenza-nel-tumore-alla-vescica-ID6049.html20%Monthly2017-05-19 11:07
http://www.dailyhealthindustry.it/pfizer-buoni-risultati-da-talazoparib-tumore-al-seno-ID6045.html20%Monthly2017-05-19 10:53
http://www.dailyhealthindustry.it/assobiomedica-al-via-campagna-di-informazione-sui-nuovi-dm-ID6043.html20%Monthly2017-05-18 17:13
http://www.dailyhealthindustry.it/pharma-india-5-anni-per-rientrare-negli-standard-internazionali-ID6038.html20%Monthly2017-05-18 16:29
http://www.dailyhealthindustry.it/meridian-i-test-per-il-piombo-nel-sangue-non-funzionano-allarme-fda-ID6036.html20%Monthly2017-05-18 15:49
http://www.dailyhealthindustry.it/al-via-pianeta-giovani-sanofi-per-gli-sport-invernali-ID6033.html20%Monthly2017-05-18 15:30
http://www.dailyhealthindustry.it/sanofi-punta-tutto-sui-biologici-ID6031.html20%Monthly2017-05-18 15:16
http://www.dailyhealthindustry.it/monsanto-da-ce-ok-per-10-anni-a-glifosfato-ID6025.html20%Monthly2017-05-18 15:02
http://www.dailyhealthindustry.it/bayer-da-fda-priority-review-per-copanlisib-linfoma-ID6020.html20%Monthly2017-05-17 16:17
http://www.dailyhealthindustry.it/fda-chiede-a-johnson-nuovo-warning-su-invokana-canaglifozin-ID6017.html20%Monthly2017-05-17 13:41
http://www.dailyhealthindustry.it/farmaci-sop-consiglio-di-stato-si-a-pubblicita-ID6015.html20%Monthly2017-05-17 13:24
http://www.dailyhealthindustry.it/farmaci-in-usa-vincono-i-generici-teva-mylan-e-novartis-sul-podio-2016-ID6012.html20%Monthly2017-05-17 13:02
http://www.dailyhealthindustry.it/sede-ema-delegazione-agenzia-a-milano-per-esame-candidatura-ID6010.html20%Monthly2017-05-17 17:42
http://www.dailyhealthindustry.it/takeda-italia-alfonso-gentile-nuovo-medical-e-regulatory-director-ID6007.html20%Monthly2017-05-17 12:12
http://www.dailyhealthindustry.it/aspen-sotto-i-riflettori-dellantitrust-europea-ID6000.html20%Monthly2017-05-16 16:30
http://www.dailyhealthindustry.it/thermo-fischer-acquista-patheon-obiettivo-la-filiera-del-laboratorio-ID5997.html20%Monthly2017-05-16 16:11
http://www.dailyhealthindustry.it/novartis-da-gsk-il-cash-per-il-big-takeover-con-astrazeneca-ID5992.html20%Monthly2017-05-16 15:12
http://www.dailyhealthindustry.it/fda-cinese-sempre-piu-occidentale-arrivano-le-concessioni-condizionate-ID5989.html20%Monthly2017-05-16 14:35
http://www.dailyhealthindustry.it/quintilesims-in-italia-aumenta-la-spesa-per-gli-antistaminici-campania-al-primo-posto-ID5985.html20%Monthly2017-05-16 12:31
http://www.dailyhealthindustry.it/valeant-riprende-fiato-con-provenge-carcinoma-alla-prostata-ok-studio-real-world-ID5983.html20%Monthly2017-05-16 11:55
http://www.dailyhealthindustry.it/astrazeneca-e-durvalumab-il-golden-bullet-delloncologia-ID5971.html20%Monthly2017-05-15 14:37
http://www.dailyhealthindustry.it/eli-lilly-bene-il-trial-su-galcanezumab-emicrania-ID5969.html20%Monthly2017-05-15 13:32
http://www.dailyhealthindustry.it/hra-pharma-italia-james-mac-donald-nuovo-general-manager-ID5966.html20%Monthly2017-05-15 16:14
http://www.dailyhealthindustry.it/gilead-da-oggi-epclusa-disponibile-in-italia-ID5962.html20%Monthly2017-05-15 15:54
http://www.dailyhealthindustry.it/msd-pronte-3000-mila-dosi-di-vaccino-contro-ebola-ID5958.html20%Monthly2017-05-15 16:18
http://www.dailyhealthindustry.it/tesaro-accordo-con-cro-per-accesso-in-europa-a-zejula-tumore-ovaio-ID5955.html20%Monthly2017-05-15 16:29
http://www.dailyhealthindustry.it/sanofi-per-il-chairman-weinberg-nessun-bisogno-di-acquisizioni-ID5951.html20%Monthly2017-05-12 16:27
http://www.dailyhealthindustry.it/ema-nel-2016-raccomandati-27-nuovi-principi-attivi-ID5948.html20%Monthly2017-05-12 15:33
http://www.dailyhealthindustry.it/melazzini-aifa-con-nuove-regole-in-manovra-meno-contenziosi-con-aziende-ID5945.html20%Monthly2017-05-12 15:18
http://www.dailyhealthindustry.it/msd-disco-verde-fda-per-combo-keytruda-chemioterapia-ID5942.html20%Monthly2017-05-12 15:25
http://www.dailyhealthindustry.it/novo-nordisk-punta-sullobesita-per-curare-il-diabete-ID5939.html20%Monthly2017-05-12 15:25
http://www.dailyhealthindustry.it/prezzi-e-accessibilita-farmaci-richiamo-delloms-il-problema-e-globale-ci-vuole-trasparenza-ID5935.html20%Monthly2017-05-12 11:38
http://www.dailyhealthindustry.it/pfizer-accordo-con-sangamo-per-candidati-terapia-genica-emofilia-ID5932.html20%Monthly2017-05-11 18:13
http://www.dailyhealthindustry.it/astrazeneca-lancia-in-i-italia-il-primo-device-elettronico-per-lasma-ID5930.html20%Monthly2017-05-11 18:13
http://www.dailyhealthindustry.it/sanofi-maggiore-omogeneita-internazionale-nelle-politiche-per-i-vaccini-ID5928.html20%Monthly2017-05-11 17:45
http://www.dailyhealthindustry.it/salix-guarda-ai-gp-con-uno-strumento-per-viaggiare-nellintestino-ID5926.html20%Monthly2017-05-11 17:35
http://www.dailyhealthindustry.it/mylan-alza-la-voce-contro-fda-che-non-approva-generico-di-advair-ID5924.html20%Monthly2017-05-11 17:25
http://www.dailyhealthindustry.it/valeant-q1-sotto-le-stime-ma-fiducia-nel-mercato-ID5922.html20%Monthly2017-05-11 16:24
http://www.dailyhealthindustry.it/a-milano-linternational-forum-on-cancer-patients-empowerment-ID5916.html20%Monthly2017-05-10 16:54
http://www.dailyhealthindustry.it/takeda-nuovo-acquisto-di-biotech-nellarea-oncologica-ID5913.html20%Monthly2017-05-10 16:09
http://www.dailyhealthindustry.it/sanofi-in-usa-aumento-prezzi-farmaci-sotto-il-5-per-cento-ID5911.html20%Monthly2017-05-10 14:30
http://www.dailyhealthindustry.it/amgen-inaugurata-scuola-a-norcia-con-fondazione-francesca-rava-ID5909.html20%Monthly2017-05-10 14:14
http://www.dailyhealthindustry.it/pfizer-merck-kgaa-ok-per-bavencio-anche-nel-cancro-alla-vescica-ID5906.html20%Monthly2017-05-10 17:15
http://www.dailyhealthindustry.it/allergan-saunders-ribadisce-niente-megafusioni-ID5904.html20%Monthly2017-05-10 12:17
http://www.dailyhealthindustry.it/scaccabarozzi-delusione-e-sconcerto-per-gli-esiti-dellindagine-di-parma-ID5902.html20%Monthly2017-05-09 17:34
http://www.dailyhealthindustry.it/mylan-studio-clinico-riaccende-la-polemica-su-epipen-ID5900.html20%Monthly2017-05-09 16:33
http://www.dailyhealthindustry.it/farmaci-innovativi-nasce-comitato-tecnico-ue-per-i-prezzi-ID5898.html20%Monthly2017-05-09 16:10
http://www.dailyhealthindustry.it/msd-per-keytruda-pembrolizumab-ce-lok-della-commissione-europea-ID5896.html20%Monthly2017-05-09 15:00
http://www.dailyhealthindustry.it/ptc-therapeutics-abbassa-il-prezzo-di-emflaza-distrofia-di-duchenne-ID5894.html20%Monthly2017-05-09 14:32
http://www.dailyhealthindustry.it/lilly-200-mln-di-euro-per-ampliare-produzione-biologici-ID5889.html20%Monthly2017-05-09 12:42
http://www.dailyhealthindustry.it/roche-e-novartis-investono-su-biotech-vivet-malattie-rare-ID5886.html20%Monthly2017-05-09 10:49
http://www.dailyhealthindustry.it/oms-modello-ebola-per-la-profilassi-del-futuro-ID5872.html20%Monthly2017-05-08 16:49
http://www.dailyhealthindustry.it/farmaci-innovativi-ad-amesterdam-si-parla-di-fair-pricing-ID5863.html20%Monthly2017-05-08 16:08
http://www.dailyhealthindustry.it/gsk-bene-relvar-in-nuovo-studio-real-world-ID5859.html20%Monthly2017-05-08 15:39
http://www.dailyhealthindustry.it/celgene-usa-dove-lexecutive-chairman-guadagna-piu-del-ceo-ID5856.html20%Monthly2017-05-08 11:28
http://www.dailyhealthindustry.it/mitsubishi-arriva-lok-fda-a-edavarone-sla-ID5854.html20%Monthly2017-05-08 16:56
http://www.dailyhealthindustry.it/biosimilari-ibg-bene-guida-ema-ue-ID5849.html20%Monthly2017-05-08 17:29
http://www.dailyhealthindustry.it/riesplode-farmacopoli-ID5845.html20%Monthly2017-05-08 18:22
http://www.dailyhealthindustry.it/dompe-disegna-la-farmacia-4-0-ID5838.html20%Monthly2017-05-05 15:16
http://www.dailyhealthindustry.it/menarini-stop-agli-abusi-sui-bambini-il-progetto-contro-la-pedofilia-ID5835.html20%Monthly2017-05-05 14:33
http://www.dailyhealthindustry.it/astrazeneca-ok-da-fda-per-durvalumab-carcinoma-uroteliale-ID5833.html20%Monthly2017-05-05 12:54
http://www.dailyhealthindustry.it/gilead-cambia-strategia-alessandro-riva-in-cabina-di-regia-ID5830.html20%Monthly2017-05-05 16:12
http://www.dailyhealthindustry.it/pfizer-xtandi-delude-nel-q1-ID5828.html20%Monthly2017-05-05 11:50
http://www.dailyhealthindustry.it/usa-cresce-la-spesa-farmaceutica-ma-il-tasso-e-sotto-il-5-per-cento-ID5825.html20%Monthly2017-05-05 11:12
http://www.dailyhealthindustry.it/sunesis-dopo-fda-anche-da-ema-boccia-vosaroxin-alzheimer-ID5819.html20%Monthly2017-05-04 17:22
http://www.dailyhealthindustry.it/bayer-e-johnson-vincono-prima-causa-usa-per-xarelto-ID5815.html20%Monthly2017-05-04 17:45
http://www.dailyhealthindustry.it/ema-a-milano-sala-ci-crede-ID5812.html20%Monthly2017-05-04 17:50
http://www.dailyhealthindustry.it/neurotrope-il-mercato-non-crede-al-candidato-per-lalzheimer-ID5809.html20%Monthly2017-05-04 16:01
http://www.dailyhealthindustry.it/astrazeneca-punta-forte-sullasma-partnership-con-biotech-da-2-mld-di-dollari-ID5807.html20%Monthly2017-05-04 17:48
http://www.dailyhealthindustry.it/boehringer-ingelheim-investe-ancora-nei-checkpoint-inhibitors-ID5805.html20%Monthly2017-05-04 15:41
http://www.dailyhealthindustry.it/merck-alessandra-aloe-consigliere-della-ssfa-ID5798.html20%Monthly2017-05-03 17:06
http://www.dailyhealthindustry.it/30-marzo-2019-fuga-da-londra-ema-suddivide-il-lavoro-fra-le-agenzie-nazionali-ID5794.html20%Monthly2017-05-03 18:05
http://www.dailyhealthindustry.it/gilead-q1-poco-felice-ma-cash-robusto-per-acquisizioni-ID5791.html20%Monthly2017-05-03 16:17
http://www.dailyhealthindustry.it/sanofi-vaccini-a-gonfie-vele-nel-q1-ID5789.html20%Monthly2017-05-03 18:00
http://www.dailyhealthindustry.it/tesaro-ce-approva-varuby-rolapitant-per-nausea-da-chemioterapia-ID5785.html20%Monthly2017-05-03 17:33
http://www.dailyhealthindustry.it/pfizer-q1-sotto-le-aspettative-read-ancora-presto-per-nuovi-accordi-ID5783.html20%Monthly2017-05-03 18:01
http://www.dailyhealthindustry.it/gsk-spinge-belysta-139-milioni-di-dollari-in-linee-produttive-ID5780.html20%Monthly2017-05-02 16:15
http://www.dailyhealthindustry.it/india-stretta-sui-prezzi-dei-md-big-pharma-a-rischio-gli-investimenti-ID5777.html20%Monthly2017-05-02 16:09
http://www.dailyhealthindustry.it/celgene-italia-jean-yves-chatelan-nuovo-vice-presidente-e-general-manager-ID5775.html20%Monthly2017-05-02 13:30
http://www.dailyhealthindustry.it/novartis-doppia-indicazione-per-rydapt-leucemia-mieloide-acuta-ID5773.html20%Monthly2017-05-02 12:55
http://www.dailyhealthindustry.it/takeda-dopo-acquisto-ariad-fda-approva-alunbrig-tumore-al-polmone-ID5771.html20%Monthly2017-05-02 12:43
http://www.dailyhealthindustry.it/astrazeneca-si-della-fda-a-imfinzi-tumore-vescica-ID5769.html20%Monthly2017-05-02 11:33